Publications by authors named "M Giladi"

Article Synopsis
  • - Tumor Treating Fields (TTFields) therapy involves a noninvasive device that applies alternating electric fields to tumors via skin arrays, and it is FDA-approved for glioblastoma and granted CE-mark for grade 4 glioma.
  • - The therapy disrupts cancer cell processes (like mitosis and DNA replication) and enhances the immune response, showing efficacy across various patient demographics with a manageable safety profile.
  • - New clinical studies are exploring TTFields therapy in combination with immunotherapy and radiotherapy, as well as in pediatric patients and other cancers, illustrating its potential as an adjunct treatment in oncology.
View Article and Find Full Text PDF

Background: Ovarian cancer is the leading cause of mortality among gynecological malignancies. Carboplatin and poly (ADP-ribose) polymerase inhibitors (PARPi) are often implemented in the treatment of ovarian cancer. Homologous recombination deficient (HRD) tumors demonstrate increased sensitivity to these treatments; however, many ovarian cancer patients are homologous recombination proficient (HRP).

View Article and Find Full Text PDF

Sodium-calcium exchanger (NCX) proteins are ubiquitously expressed and play a pivotal role in cellular calcium homeostasis by mediating uphill calcium efflux across the cell membrane. Intracellular calcium allosterically regulates the exchange activity by binding to two cytoplasmic calcium-binding domains, CBD1 and CBD2. However, the calcium-binding affinities of these domains are seemingly inadequate to sense physiological calcium oscillations.

View Article and Find Full Text PDF

The translocator protein 18 kDa (TSPO) is an evolutionarily conserved mitochondrial transmembrane protein implicated in various neuropathologies and inflammatory conditions, making it a longstanding diagnostic and therapeutic target of interest. Despite the development of various classes of TSPO ligand chemotypes, and the elucidation of bacterial and non-human mammalian experimental structures, many unknowns exist surrounding its differential structural and functional features in health and disease. There are several limitations associated with currently used computational methodologies for modelling the native structure and ligand-binding behaviour of this enigmatic protein.

View Article and Find Full Text PDF

Cytosolic Ca and Na allosterically regulate Na/Ca exchanger (NCX) proteins to vary the NCX-mediated Ca entry/exit rates in diverse cell types. To resolve the structure-based dynamic mechanisms underlying the ion-dependent allosteric regulation in mammalian NCXs, we analyze the apo, Ca, and Na-bound species of the brain NCX1.4 variant using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and molecular dynamics (MD) simulations.

View Article and Find Full Text PDF